Physicians are cautioned that the two obstacles to reforming post-marketing clinical trials are the FDA's reluctance to revisit past approvals and its inability to enforce pharmaceutical companies' commitment to conduct Phase IV trials.
Two bioethicists argue that prenatal disability screening promotes negativity toward the disabled and gives parents the ability to selectively form families.
A philosophy professor argues that prenatal genetic testing allows potentially painful afflictions to be discovered prior to birth and does not unjustly discriminate against disabled people.
Health care professionals have a responsibility to educate patients about public screening programs and ensure that subsequent follow-up is done after the screening is completed.
Cross-cultural ethics should be regarded by physicians as an area of medical expertise that can help resolve conflicts that arise between the health traditions of international patients and those traditions that are upheld in the United States.